Cargando…
Nitric Oxide Releasing Nanoparticles for Treatment of Candida Albicans Burn Infections
Candida albicans is a leading fungal cause of burn infections in hospital settings, and sepsis is one of the principle causes of death after a severe burn. The prevalence of invasive candidiasis in burn cases varies widely, but it accounts for 3–23% of severe infection with a mortality rate ranging...
Autores principales: | Macherla, Chitralekha, Sanchez, David A., Ahmadi, Mohammed S., Vellozzi, Ernestine M., Friedman, Adam J., Nosanchuk, Joshua D., Martinez, Luis R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Research Foundation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3370663/ https://www.ncbi.nlm.nih.gov/pubmed/22701111 http://dx.doi.org/10.3389/fmicb.2012.00193 |
Ejemplares similares
-
Nitric Oxide-Releasing Nanoparticles Are Similar to Efinaconazole in Their Capacity to Eradicate Trichophyton rubrum Biofilms
por: Costa-Orlandi, Caroline Barcelos, et al.
Publicado: (2021) -
Nitric Oxide Releasing Nanoparticles Are Therapeutic for Staphylococcus aureus Abscesses in a Murine Model of Infection
por: Han, George, et al.
Publicado: (2009) -
The potential of nitric oxide releasing therapies as antimicrobial agents
por: Schairer, David O., et al.
Publicado: (2012) -
Antibiofilm Activities of Biogenic Silver Nanoparticles Against Candida albicans
por: Ahamad, Irshad, et al.
Publicado: (2022) -
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
por: Whaley, Sarah G., et al.
Publicado: (2017)